James Buxbaum

James Buxbaum, MD is a Professor of Medicine and Executive Director of the Digestive Health Institute at Keck Medicine of USC. As a national leader in advanced endoscopy and pancreatology, he specializes in complex biliary problems including recurrent pyogenic cholangitis and post-liver transplant strictures, with research focusing on pancreatic biomarker development and endoscopic management of pancreatic neoplasms.

• Medical Degree: University of California, San Francisco
• Fellowships: Gastroenterology and Advanced Endoscopy at UCSF

Research Interests cover:

• Pancreatic cancer early detection via endoscopic ultrasound
• Machine learning applications in pancreatitis management
• Optimization of ERCP outcomes
• Biliary disease interventions
• Gastrointestinal cancer screening

2025 Publications demonstrate leadership in:

• Fluid therapy protocols for acute pancreatitis
• Pancreatic stent placement optimization
• AI-guided endoscopic decision-making
• Post-ERCP care protocols

Scientific Recognition:

• Fellow, American Society for Gastrointestinal Endoscopy (2014)
• Pasadena Magazine Top Doctor (2011)
• NIH-funded research programs
• Associate Editor, Gastrointestinal Endoscopy

As a clinical scholar, Dr. Buxbaum integrates research into his academic medical practice while maintaining active clinical roles in endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), and complex gastrointestinal procedures.